Skip to main content

Potenzial des analgetischen Placeboeffekts in der Rückenschmerztherapie

  • Chapter
Book cover Rückenschmerzen und Nackenschmerzen
  • 9145 Accesses

Zusammenfassung

Die Forschung zur Placebowirksamkeit gewinnt in den letzten Jahren eine zunehmende klinisch-praktische Bedeutung. Es wird nicht mehr nur von einem allgemeinen, unspezifischen Placeboeffekt ausgegangen, sondern es konnte gezeigt werden, dass es viele, krankheitsspezifische Placeboeffekte gibt. Die Erkenntnisse auf diesem Gebiet, insbesondere auch der verschiedenen zugrundeliegenden Mechanismen, machen den Placeboeffekt zu einem potenziell nachvollziehbaren Prozess, der klinische Therapien, medikamentöse wie auch psychotherapeutische, effektiver gestalten kann. Der analgetische Placeboeffekt nimmt hierbei eine zentrale Position ein, er ist am weitesten erforscht und wird in der S3-Leitlinie der AWMF zur »Behandlung akuter und perioperativer Schmerzen« zur klinischen Nutzung empfohlen. Diese Empfehlung ist eine bedeutsame Innovation in der Anwendung medikamentöser Schmerztherapie und eröffnet auch innovative Wege zur Behandlung chronischer Rückenschmerzen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Ader R (1997) Processes underlying placebo effects — The preeminence of conditioning. Pain Forum 6(1):56–58

    Article  Google Scholar 

  2. Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19(1):484–494

    CAS  PubMed  Google Scholar 

  3. Bandura A, Ross SA, Ross D (1963) A Comparative Test of Status Envy, Social Power, and Secondary Reinforcement Theories of Identificatory Learning. J Abnorm Psychol 67(6):527–534

    Article  CAS  PubMed  Google Scholar 

  4. Benedetti F (2006) Placebo analgesia. Neurol Sci 27(Suppl 2):-100–102

    Article  Google Scholar 

  5. Benedetti F, Arduino C, Amanzio M (1999) Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci 19(9):3639–3648

    CAS  PubMed  Google Scholar 

  6. Benedetti F, Amanzio M, Baldi S, Casadio C, Maggi G (1999) Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci 11:625–631

    Article  CAS  PubMed  Google Scholar 

  7. Benedetti F, Maggi G, Lopiano L, Lanotte M, Rainerao I, Vighetti S (2003) Open versus hidden medical treatments: the patient’s knowledge about therapy affects the therapy outcome. Prevention Treatment. doi:10.1037/1522-3736.6.1.61a

  8. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I (2003) Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 23(10):4315–4323

    CAS  PubMed  Google Scholar 

  9. Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I et al (2006) Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain 121 (1–2):133–144

    Article  CAS  PubMed  Google Scholar 

  10. Brody HBD (2002) Der Placebo-Effekt. Die Selbstheilungskräfte unseres Körpers. DTV, München

    Google Scholar 

  11. Colloca L, Benedetti F (2006) How prior experience shapes placebo analgesia. Pain 124:126–133

    Article  PubMed  Google Scholar 

  12. Colloca L, Benedetti F (2009) Placebo analgesia induced by social observational learning. Pain 144(1–2):28–34

    Article  PubMed  Google Scholar 

  13. Colloca L, Miller FG (2011) The Nocebo Effect and Its Relevance for Clinical Practice. Psychosomatic Medicine 73: 598–603

    Article  PubMed  PubMed Central  Google Scholar 

  14. Colloca L, Lopiano L, Lanotte M, Benedetti F (2004) Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol 3(11):679–684

    Article  PubMed  Google Scholar 

  15. Colloca L, Sigaudo M, Benedetti F (2008a) The role of learning in nocebo and placebo effects. Pain 136(1–2):211–218

    Google Scholar 

  16. Colloca L, Tinazzi M, Recchia S, Le Pera D, Fiaschi A, Benedetti F et al (2008b) Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 139(2):306–314

    Article  PubMed  Google Scholar 

  17. Colloca L, Klinger R, Flor H, Bingel U (2013) Placebo analgesia: psychological and neurobiological mechanisms. Pain 154: 511–514

    Article  PubMed  PubMed Central  Google Scholar 

  18. DIVS (2008) S3-Leitlinie Behandlung akuter perioperativer und posttraumatischer Schmerzen (Bd AWMF-Reg.-Nr. 041/001). Deutscher Ärzte-Verlag, Köln

    Google Scholar 

  19. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J et al (2009) Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63(4):533–543

    Article  CAS  PubMed  Google Scholar 

  20. Eippert F, Finsterbusch J, Bingel U, Buchel C (2009) Direct evidence for spinal cord involvement in placebo analgesia. Science 326(5951):404

    Article  CAS  PubMed  Google Scholar 

  21. Enck P, Benedetti F, Schedlowski M (2008) New insights into the placebo and nocebo responses. Neuron 59(2):195–206

    Article  CAS  PubMed  Google Scholar 

  22. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F (2010) Biological, clinical, and ethical advances of placebo effects. Lancet 375(9715):686–695

    Article  PubMed  PubMed Central  Google Scholar 

  23. Henschke N, Kuijpers T, Rubinstein SM, van Middelkoop M, Ostelo R, Verhagen A, Koes BW, van Tulder, MW (2010) Injection therapy and denervation procedures for chronic low-back pain: a systematic review. Eur Spine J (2010) 19:1425–1449. doi:10.1007/s00586-010-1411-0

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hrobjartsson A, Gotzsche PC (2003) Unreliable analysis of placebo analgesia in trials of placebo pain mechanisms. Pain 104(3): 714–715; author reply 715–716

    Article  PubMed  Google Scholar 

  25. Hrobjartsson A, Gotzsche PC (2004) Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 256(2): 91–100

    Article  CAS  PubMed  Google Scholar 

  26. Kirsch I (1978) Placebo effect and cognitive-behavioral r evolution. Cognit Ther Res 2(3):255–264

    Article  Google Scholar 

  27. Kirsch I (1985) Response expectancy as a determinant of experience and behaviour. Am Psychol 40:1189–1202

    Article  Google Scholar 

  28. Kirsch I (1990) Changing expectations: a key to effective psychotherapy. Brooks/Cole, Pacific Grove, S 231

    Google Scholar 

  29. Kirsch I (1997) Expectancy and conditioning in placebo analgesia — related or independent mechanisms? Pain Forum 6(1):59–61

    Article  Google Scholar 

  30. Kirsch I (1997) Specifying nonspecifics: psychological mechanisms of placebo effects. In: Harrington A (Hrsg) The placebo effect: an interdisciplinary exploration. Cambridge UP, Cambridge, S 166–186

    Google Scholar 

  31. Kirsch I, Lynn S J, Vigorito M, Miller RR (2004) The role of cognition in classical and operant conditioning. J Clin Psychol 60(4):369–392

    Article  PubMed  Google Scholar 

  32. Klinger R (2010) Das Potenzial des analgetischen Plazeboeffektes: S3-Leitlinien-Empfehlung zur Behandlung akuter und perioperativer Schmerzen. Anästhesiol Intensivmed Notfallmed Schmerzther (45):22–29

    Google Scholar 

  33. Klinger R, Flor H (2014) Clinical and ethical implications of placebo effects: enhancing patients’ benefits from pain treatment. In: Benedetti F et al (Hrsg) Placebo, handbook of experimental pharmacology 225. Springer, Berlin, S 217–235. doi:10.1007/978-3-662-44519-8_13

    Google Scholar 

  34. Klinger R, Soost S, Flor H, Worm M (2007) Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain 128(1–2):31–39

    Article  PubMed  Google Scholar 

  35. Klinger R, Becker M, Bryant M, Thomm M (2008) Allgemeine Patienteninformation und -schulung. In: D.D.i.V.f. Schmerztherapie (Hrsg) S3-Leitlinie Behandlung akuter und perioperativer posttraumatischer Schmerzen. Deutscher Ärzte-Verlag, Köln, S 19–22

    Google Scholar 

  36. Klinger R, Colloca L, Bingel U, Flor H (2014) Placebo analgesia: Clinical applications. Pain 155:1055–1058

    Article  PubMed  Google Scholar 

  37. Levine JD, Gordon NC, Fields HL (1978) The mechanism of placebo analgesia. Lancet 2(8091):654–657

    Article  CAS  PubMed  Google Scholar 

  38. Millan M J (2002) Descending control of pain. Prog Neurobiol 66(6):355–474

    Article  CAS  PubMed  Google Scholar 

  39. Montgomery GH, Kirsch I (1997) Classical conditioning and the placebo effect. Pain 72:107–113

    Article  CAS  PubMed  Google Scholar 

  40. Petrovic P, Kalso E, Petersson KM, Ingvar M (2002) Placebo and opioid analgesia — imaging a shared neuronal network. Science 295(5560):1737–1740

    Article  CAS  PubMed  Google Scholar 

  41. Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F (2001) Response expectancies in placebo analgesia and their clinical relevance. Pain 93(1):77–84

    Article  CAS  PubMed  Google Scholar 

  42. Price DD, Fields HL (1997) The contribution of desire and expectation to placebo analgesia: implications for new research strategies. In: Harrington A (Hrsg) The placebo effect: an interdisciplinary exploration. Harvard UP, Cambridge, S 117–137

    Google Scholar 

  43. Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS (1999) An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83:147–156

    Article  CAS  PubMed  Google Scholar 

  44. Price DD, Craggs J, Verne GN, Perlstein WM, Robinson ME (2007) Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127(1–2):63–72

    Article  PubMed  Google Scholar 

  45. Price DD, Finniss DG, Benedetti F (2008) A comprehensive review of the placebo effect: Recent advances and current thought. Annu Rev Psychol 59:565–590

    Article  PubMed  Google Scholar 

  46. Siegel S (1985) Drug-anticipatory responses in animals. In: White L, Tursky B, Schwartz GE (Hrsg) Placebo: theory, research and mechanisms. Guilford, New York, S 288–305

    Google Scholar 

  47. Siegel S (2002) Explanatory mechanisms for placebo effects: Pavlovian conditioning. In: Guess HA, Kleinman A, Kusek JW, Engel LW (Hrsg) The science of the placebo: toward an interdisciplinary research agenda. BMJ Books, London, S 133–157

    Google Scholar 

  48. Staal JB, de Bie R, de Vet HCW, Hildebrandt J, Nelemans P (2010). Injection therapy for subacute and chronic low-back pain an updated Cochrane review. Spine (Phila Pa 1976) 34(1):49–59. doi:10.1097/BRS.0b013e3181909558

    Article  Google Scholar 

  49. Stewart-Williams S, Podd J (2004) The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 130(2):324–340

    Article  PubMed  Google Scholar 

  50. Thieme K, Turk D, Flor H (2007) Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome. Arthritis Rheum 57(5):830–836

    Article  PubMed  Google Scholar 

  51. Turner JA, Deyo RA, Loeser JD, Vonkorff M, Fordyce WE (1994) The importance of placebo-effects in pain treatment and research. Jama 271(20):1609–1614

    Article  CAS  PubMed  Google Scholar 

  52. Vase L, Riley JL 3rd, Price DD (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99(3):443–452

    Article  PubMed  Google Scholar 

  53. Vase L, Robinson ME, Verne GN, Price DD (2003) The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 105:17–25

    Article  PubMed  Google Scholar 

  54. Vase L, Petersen GL, Riley JL 3rd, Price DD (2009) Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain 145(1–2):36–44

    Article  PubMed  Google Scholar 

  55. Vlaeyen JWS, Linton SJ (2000) Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85: 317–332

    Article  CAS  PubMed  Google Scholar 

  56. Voudouris NJ, Peck CL, Coleman G (1985) Conditioned placebo responses. J Pers Soc Psychol 48:47–53

    Article  CAS  PubMed  Google Scholar 

  57. Voudouris NJ, Peck CL, Coleman G (1989) Conditioned response models of placebo phenomena: further support. Pain 38:109–116

    Article  CAS  PubMed  Google Scholar 

  58. Voudouris NJ, Peck CL, Coleman G (1990) The role of conditioning and verbal expectancy in the placebo response. Pain 43:121–128

    Article  CAS  PubMed  Google Scholar 

  59. Wager TD, Scott DJ, Zubieta JK (2007) Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci USA 104(26):11056–11061

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Wall P (1999) Textbook of pain. Churchill Livingstone, Edinburgh

    Google Scholar 

  61. Watson A, El-Deredy W, Iannetti GD, Lloyd D, Tracey I, Vogt B A et al (2009) Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception. Pain 145(1–2):24–30

    Article  PubMed  PubMed Central  Google Scholar 

  62. Wickramasekera I (1980) A conditioned response model of the placebo effect predictions from the model. Biofeedback Self Regul 5(1):5–18

    Article  CAS  PubMed  Google Scholar 

  63. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA et al (2005) Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25(34):7754–7762

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Klinger, R., Flor, H. (2016). Potenzial des analgetischen Placeboeffekts in der Rückenschmerztherapie. In: Casser, HR., Hasenbring, M., Becker, A., Baron, R. (eds) Rückenschmerzen und Nackenschmerzen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29775-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-29775-5_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-29774-8

  • Online ISBN: 978-3-642-29775-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics